Hydrophobic profiles of the tail anchors in SLMAP dictate subcellular targeting by Byers, Joseph T et al.
BioMed  Central
Page 1 of 18
(page number not for citation purposes)
BMC Cell Biology
Open Access Research article
Hydrophobic profiles of the tail anchors in SLMAP dictate 
subcellular targeting
Joseph T Byers, Rosa M Guzzo, Maysoon Salih and Balwant S Tuana*
Address: Department of Cellular and Molecular Medicine, 451 Smyth Road, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada
Email: Joseph T Byers - joseph.t.byers@gmail.com; Rosa M Guzzo - rosaguzzo@yahoo.com; Maysoon Salih - msalih@uottawa.ca; 
Balwant S Tuana* - btuana@uottawa.ca
* Corresponding author    
Abstract
Background:  Tail anchored (TA) membrane proteins target subcellular structures via a C-
terminal transmembrane domain and serve prominent roles in membrane fusion and vesicle
transport. Sarcolemmal Membrane Associated Protein (SLMAP) possesses two alternatively spliced
tail anchors (TA1 or TA2) but their specificity of subcellular targeting remains unknown.
Results: TA1 or TA2 can direct SLMAP to reticular structures including the endoplasmic reticulum
(ER), whilst TA2 directs SLMAP additionally to the mitochondria. Despite the general structural
similarity of SLMAP to other vesicle trafficking proteins, we found no evidence for its localization
with the vesicle transport machinery or a role in vesicle transport. The predicted transmembrane
re gi on  o f  T A 2  i s f l a n k e d  on  e i t h e r  s i d e  b y  a positively charged amino acid and is itself less
hydrophobic than the transmembrane helix present in TA1. Substitution of the positively charged
amino acids, in the regions flanking the transmembrane helix of TA2, with leucine did not alter its
subcellular targeting. The targeting of SLMAP to the mitochondria was dependent on the
hydrophobic nature of TA2 since targeting of SLMAP-TA2 was prevented by the substitution of
leucine (L) for moderately hydrophobic amino acid residues within the transmembrane region. The
SLMAP-TA2-4L mutant had a hydrophobic profile that was comparable to that of SLMAP-TA1 and
had identical targeting properties to SLMAP-TA1.
Conclusion: Thus the overall hydrophobicity of the two alternatively spliced TAs in SLMAP
determines its subcellular targeting and TA2 predominantly directs SLMAP to the mitochondira
where it may serve roles in the function of this organelle.
Background
The tail-anchored (TA) membrane proteins include
diverse family members such as cytochrome b5, DMPK A,
& C, Bcl-2, Tom, and Sec61 b & g which are critical for cell
function [1-8]. Several of these proteins, such as Synapto-
brevin, are important in vesicle transport and membrane
fusion [9]. The tail-anchor of TA proteins is defined as the
C-terminal hydrophobic transmembrane domain which
may be flanked by hydrophilic amino acid residues
[9,10]. The Tail-Anchors can target proteins to a wide
range of subcellular compartments including the ER
(endoplasmic reticulum) [11-13], the MOM (mitochon-
drial outer membrane) [14-17], peroxisomes [18,19], the
perinuclear membrane [20] and the chloroplast outer
envelope in plants [21]. The molecular mechanism by
which tail anchored proteins target specific membranes is
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of much interest. There appears to be no consensus amino
acid sequence in the different TAs of proteins that dictate
their targeting. In fact the sequence of the amino acids in
the transmembrane domain has been shown to be irrele-
vant in synaptobrevin, where a poly-leucine tail (13
amino acids) targets the protein to the ER [22]. However,
all tail anchors are predominantly hydrophobic in nature,
as determined from the amino acid sequence of the mem-
brane spanning region. Some studies indicate that there
may be recognition motifs contained within the TA for
proteins such as PEX26 and PEX15p, which cause them to
target the peroxisome [23]. No such motifs have been
identified for TAs which target proteins to the ER or the
MOM. However, some TAs which target proteins to the
MOM, are flanked by positively-charged residues adjacent
to the membrane-spanning region which are believed to
dictate their targeting to either the ER, or both the ER and
the MOM [2,24-26]. This has led to the view that the p osi-
tive charges individually or collectively in and around the
TA determines its subcellular targeting [21,26]. Other
studies by Biellharz et al., [20], Brambillasca et al., [27]
and Wattenberg et al., [28] have provided evidence that
the hydrophobicity of a tail anchor sequence itself can
also influence which organelle it will target. Weather this
is a unifying concept involved in targeting all TAs remains
to be explored. The Sarcolemmal Membrane Associated
Protein (SLMAP, formerly known as SLAP) is a tail-
anchored protein which can carry two alternatively
spliced TAs [8,29]. All SLMAP isoforms are encoded by
one gene and many SLMAP isoforms have now been
shown to be expressed in a tissue specific manner with
proposed roles in myoblast fusion, excitation-contraction
coupling and centrosomal organization [8,29-32]. The
largest SLMAP isoform, the 91 kDa SLMAP3, is ubiqui-
tously expressed in all tissues whilst the smallest isoform,
the 34 kDa SLMAP1, is only expressed in cardiac and mus-
cle tissue [30]. Each SLMAP isoform shares the C-terminal
region of the protein but the smaller isoforms do not pos-
sess the N-terminal structures such as the FHA domain
[8].
We have previously shown that when TA1 or TA2 are
encoded as part of SLMAP1 they direct it to subcellular
membrane structures [31] but which organelles they tar-
get and how, has not been defined. In addition, we have
found that SLMAP carrying either TA1 or TA2 can be dif-
ferentially expressed in the same tissue [8] Further more,
immunohistological and biochemical analysis implies
that SLMAP localizes in different subcellular compart-
ments within the cardiomyocytes including the sarco-
lemma, SR/ER, and the transverse tubules [29,31]. TA1
comprises 27 amino acid residues with a predicted trans-
membrane helix of 18 residues and TA2 comprises 30
amino acid residues with a predicted transmembrane
helix of 19 residues [8]. In this study we identify how TA1
and TA2 affect the subcellular targeting of SLMAP1 in
Cos7 cells and provide evidence which supports the view
that the overall hydrophobic profile of a tail anchor is crit-
ical for determining its subcellular localization. Further
more, our analysis indicates that SLMAP1 itself is not
involved in vesicle transport but can target the ER as well
as the mitochondria, possibly the MOM, where it may
play previously unrecognized roles in the subcellular
function of these organelles.
Results
SLMAP is a component of intracellular membranes in non-
muscle cells
The SR is derived from smooth endoplasmic reticulum, an
extensive membrane-bound organelle, which contributes
to general intracellular calcium regulation in eukaryotic
cells [33]. In view of the abundant SLMAP expression in
the SR of cardiac cells and the ubiquitous distribution of
the 91 kDa SLMAP varient [30], we sought to determine
whether this SLMAP isoform is also a component of mem-
brane systems (ER, Golgi) in non-muscle cells. Micro-
somes were prepared from the postnuclear supernatant of
rat liver homogenates and further separated into ER and
Golgi fractions by sucrose gradient centrifugation (Figure
1) [34]. Protein fractions from each gradient were col-
lected and separated by SDS-PAGE and subjected to
immunoblot analysis using anti-SLMAP antibodies as
well as specific markers of the ER (calnexin) and a cis-
Golgi marker (a-mannosidase). A 91 kDa SLMAP isoform,
consistent with the molecular size of the full length
SLMAP protein, distributed with calnexin in fractions B1
and SGF3 but was not enriched in the fractions with the
highest levels of calnexin (S3, C1 and C2) (Figure 1).
SLMAP was absent in the stack Golgi fraction where a-
mannosidase was enriched, and was present in SGF3 and
SGFL together with some calnexin (Figure 1). These data
suggest that SLMAP is not a resident of the Golgi although
it may be present in specific regions of the ER in the liver.
It seems likely that the difference between the distribution
of SLMAP and calnexin is due to a combination of the
properties of the tail anchors in the liver SLMAP as well as
the lipid composition in the different forms and regions
of the ER.
Tail anchors in SLMAP target distinct subcellular 
membranes
In order to determine weather the two carboxyl-terminal
TAs utilized by SLMAP can target to distinct membrane
structures, 6Myc-tagged SLMAP1 carrying TA1 or TA2 was
transfected in COS7 and its localization monitored rela-
tive to various components of intracellular organelles.
SLMAP1 is a 34 kDa isoform which is expressed predom-
inantly in cardiac and muscle tissue, and was found to be
an integral membrane protein [30]. Co-staining with the
ER marker calnexin demonstrated significant co-distribu-BMC Cell Biology 2009, 10:48 http://www.biomedcentral.com/1471-2121/10/48
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tion with 6Myc-SLMAP1-TA1 at reticular formations (Fig-
ure 2A; a–c); however limited co-distribution was
observed in cells expressing 6Myc-SLMAP1-TA2 (Figure
2A; d–f). Since SLMAP contains a coiled-coil leucine zip-
per involved in homodimerization [32], we investigated
whether this motif will influence targeting. As shown,
(Figure 2A; g–i) a deletion mutant lacking the leucine zip-
per (DLZ) 6Myc-SLMAP1-TA2DLZ had identical targeting
when compared to the undeleted, expressed protein. Anti-
ERGIC-53 monoclonal antibodies were used to detect the
ER-Golgi intermediate compartment and consistently
labelled fine punctuate structures concentrated at perinu-
clear sites in COS7 cells [35,36]. This distribution pattern
was distinct from that of either 6Myc-SLMAP1-TA1 (Fig-
ure 2B; a–c) or 6 Myc-SLMAP1-TA2 (Figure 2B; d–f).
Whereas Myc staining demonstrated that TA1 and TA2
direct SLMAP1 to perinuclear sites, no co-localization
with the anti-Golgi58K monoclonal antibody was noted
(Figure 2C; a–i). Further, the fungal metabolite Brefeldin
A, a widely used agent that disrupts the structure of the
Golgi apparatus [37,38] did not alter the subcellular dis-
tribution of SLMAP1 (data not shown).
Disruption of the cytoskeleton and SLMAP localization
We examined the localization of endogenous SLMAP with
anti-SLMAP antibodies and compared this with the ER
marker calnexin using anti-calnexin antibodies and a clear
co-distribution of these two proteins is evident (Figure 3A;
a–c). The importance of cytoskeleton for the organization
of the membrane organelles such as the ER has been dem-
onstrated by the pharmacological disruption of microtu-
bules [33]. In cells treated with the microtubule
depolymerising agent nocodazole, the ER membrane col-
lapses and aggregates around the nucleus [39-41]. Under
conditions that disrupt microtubules, the distribution of
the ectopically expressed ER-membrane associated
SLMAP1 variant (6Myc-SLMAP1-TA1) was altered from a
reticular-like distribution (Figure 3B; a) to an aggregate-
like distribution (Figure 3B; b). These nocodazole-
induced structures were not however observed in COS7
cells expressing SLMAP1 deletion mutant lacking the TA
(6Myc-SLMAP1DTA) (Figure 3B; c). The effect of nocoda-
zole on microtubule assembly was confirmed by staining
with a-tubulin, which illustrated a distinct redistribution
of the cytoplasmic microtubules (Figure 3B; d–f). These
observations imply that SLMAP1-membrane associations
require an intact microtubule network and would be con-
sistent with the distribution of SLMAP1-TA1 at the ER
membrane.
To determine whether SLMAPs are associated with the
actin cytoskeleton, COS7 cells expressing 6Myc-SLMAP1
fusion proteins were treated with cytochalasin D, an actin
myofilament disrupting agent [42]. Depolymerization of
the actin filaments with cytochalasin D did not alter the
localization of 6Myc-SLMAP1 fusion proteins carrying
either TA1 (Figure 3C; a, b) or TA2 (Figure 3C; c, d), whilst
inducing actin-containing microfilaments to change from
filamentous (Figure 3C; e, g) to punctuate structures (Fig-
ure 3C; f, h).
SLMAP and ER-Golgi transport
Comparisons of the predicted primary structure of SLMAP
indicates general similarities with coiled-coil TA anchored
Sub cellular distribution of SLMAP from liver Figure 1
Sub cellular distribution of SLMAP from liver. Rat liver homogenate was fractionated by sucrose gradient centrifugation. 
Western blot analysis demonstrated that the cis-Golgi marker, a-mannosidase resides in the stacked Golgi fraction 1 (lane 
SGF1). Endogenous SLMAP (91 kDa) proteins are distributed among fractions where the ER marker calnexin is expressed 
(lanes B1; S3; SGF3). H (homogenate); PNS (postnuclear supernatant); SGF (stacked Golgi fraction); P (pellet).BMC Cell Biology 2009, 10:48 http://www.biomedcentral.com/1471-2121/10/48
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Subcellular membrane distribution of SLMAP Figure 2
Subcellular membrane distribution of SLMAP. (A) COS7 cells transiently transfected with 6Myc-tagged SLMAP variants 
encompassing either TA1 (A; a-c), TA2 (A; d-f) or DLZ_TA2 (g-i) were stained with anti-calnexin polyclonal antibodies (b, e, h). 
The overlay of the anti-Myc and calnexin in these cells is shown in A; c, f, i. SLMAP distribution with respect to the secretory 
system. (B) COS7 cells transfected with either 6Myc-SLMAP-TA1 (B; a-c) or 6Myc-SLMAP1-TA2 (d-f) were stained with anti-
SLMAP (B; a, d) and anti-ERGIC-53 (B; b, e), with the overlay shown in B; c, f. SLMAP distribution with respect to the Golgi 
apparatus. (C) COS7 cells expressing either 6Myc-SLMAP-TA1 (C; a-c); 6Myc-SLMAP-TA2 (C; d-f) or 6Myc-SLMAPDLZ-TA2 
(g-i), were co-stained with anti-Golgi 58 K (C; b, e, h) and anti-SLMAP (a, d, g), with the overlay shown in C; c, f, i. Scale bar = 
10 mm.
B 
C 
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SLMAP localizes to the ER and its associations are microtubule dependent Figure 3
SLMAP localizes to the ER and its associations are microtubule dependent. (A), COS7 cells were stained with anti-
SLMAP (A; a) and anti-calnexin (A; b) and merged image (A; c). (B), COS7 cells were transfected with 6Myc-SLMAP-TA1 (B; a, 
b, d, e) and 6Myc-SLMAPDTM (B; c, f) and stained with Anti-SLMAP (B; a-c) and anti-a-tubulin (B; d-f). Cells treated with noc-
odazole (B; b, c, e, f). (C) COS7 cells transfected with either 6Myc-SLMAP-TA1 (C; a, b, e, f) or 6Myc-SLMAP-TA2 (C; c, d, g, 
h) and stained with phalloidin (C; e-h) and anti-Myc (a-d). Treatment with cytochalasin D (C; f, h) did not alter the distribution 
of the 6Myc-SLMAP-TA1 (C; b) or 6Myc-SLMAP-TA2 (C; d). Scale bar = 10 mm.BMC Cell Biology 2009, 10:48 http://www.biomedcentral.com/1471-2121/10/48
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proteins involved in transport of vesicles from the ER and
the docking of vesicles at the Golgi [43,44]. Analysis of the
amino acid sequences encoding SLMAPs (Accession No.
AAA65597) also indicated the presence of a putative di-
acidic sorting signal upstream of the carboxyl-terminal
transmembrane domain. (EQE) Di-acidic motifs, defined
by Asp/Glu residues separated by a variable residue (D/
E)X(D/E), are often located in close proximity to tyrosine-
based sorting motifs (YXXö) and are thought to mediate
efficient export of the protein from the ER by interacting
with the vesicular transport machinery [45,46]. In SLMAP a
tyrosine-based sorting motif (YEKT) is present upstream of
the di-acidic sorting motif. In view of these features we
investigated whether SLMAPs are involved in vesicular
transport from the ER to the Golgi. Previous studies have
shown that overexpression of coiled-coil membrane pro-
teins involved in vesicle trafficking from the ER to Golgi
inhibit protein export from the ER [47]. To examine this
possibility, COS7 cells were co-transfected with an ER-
localized 6Myc-SLMAP1 and the GFP-tagged glycoprotein
of the temperature sensitive strain of vesicular stomatitis
virus (ts045-VSV-G-GFP), which serves as a marker of ER to
Golgi transport. When maintained at the restrictive temper-
ature (39.5°C), the viral glycoprotein could not be
exported from the ER due to a thermoreversible-folding
defect (Figure 4d) and consequently co-distributed with
6Myc-SLMAP1 (Figure 4a &4g). Proper folding and subse-
quent transport out of the ER to the Golgi and cell periph-
ery was achieved when the ts045-VSV-G transfected cells
were incubated at the permissive temperature (32°C).
Whereas the GFP-labelled viral glycoprotein was trans-
ported out of the ER to the Golgi and plasma membrane
under conditions that promote vesicular transport (Figure
4e), the 6Myc-SLMAP fusion protein did not appear to exit
the ER (Figure 4b) as clearly indicated in the overlay (Figure
4h). Expression of the SLMAP1 lacking either the trans-
membrane domain or the leucine zipper motifs did not
affect the ability of the viral glycoprotein to exit the ER at
the permissive temperature (data not shown). COS7 cells
co-expressing ts045-VSV-G-GFP and 6Myc-SLMAP1 were
also incubated at reduced temperatures to monitor whether
SLMAP1 cycles from the ER to the ERGIC [48]. At 15°C the
membrane associated SLMAP1 was retained in the ER (Fig-
ure 4c), whereas the GFP-labelled viral glycoprotein was
visualized as vesicular clusters concentrated at perinuclear
sites (Figure 4f) consistent with localization at the ERGIC
(Figure 4i). Collectively, these studies indicate that SLMAP1
is not exported via the vesicular transport process nor does
elevated expression of SLMAP1 affect transport and is con-
sistent with its absence from the stack Golgi fraction.
Hydrophobic profiles of the TAs in SLMAP
A single gene encodes SLMAP which undergoes alternative
splicing to generate distinct isoforms with unique tail
anchors which serve roles in myoblast fusion, centro-
somal function and excitation-contraction coupling
[29,31,32]. Exon XXIII (of SLMAP) encodes 27 amino
acids which comprise the alternatively spliced TA, referred
to as TA1. Exon XXIV encodes 30 amino acids which form
the constitutively expressed TA, referred to as TA2 [8,29].
To more clearly define SLMAP targeting, the nature of the
TAs in SLMAP was explored using the HMMTOP program
which predicted that SLMAP's two alternatively spliced C-
terminal exons contain a single putative transmembrane
domain [49,50] (Figure 5A). TA1, encoded by Exon XXIII,
contains a predicted transmembrane helix of 18 amino
acids flanked by five amino acid residues at the N-termi-
nal end and four residues at the C-terminal end. TA2,
encoded by Exon XXVI, is predicted to contain a trans-
membrane helix of nineteen amino acids flanked by seven
residues at the N-terminal end and five residues at the C-
terminus. The two TAs have no sequence homology, but
have similar properties, in that they are largely hydropho-
bic domains (Figure 5B). The major difference between
the two TAs is the presence of a basic amino acid residue
on either flank of the membrane spanning region in TA2,
which are not present in TA1 (Figure 5A).
Numerous reports have shown that the presence of posi-
tively charged residues in the regions flanking the mem-
brane spanning region can cause a TA to target the MOM
rather that the ER [2,24,25]. A simple examination of the
flanking sequences of TA1 and TA2 shows that only TA2
possesses positively charged residues in this region (Figure
5A). This suggests that TA2 may target the MOM whilst
TA1 could target the ER. However, some ER targeting TAs
possesses positively charged residues in the flanking
regions [2,3,14,22], so we might conclude that there may
be additional factors involved in the targeting of TAs. It
has been shown that the hydrophobicity of the transmem-
brane region can affect the membrane targeting of a TA
[20,27].
The hydrophobicity of the TA1 and TA2 was calculated
using the Eisenberg normalised scale with a window size
of 9, the relative weight for window edges was 100% (Fig-
ure 5B) [51]. The hydrophobicity scores for the two puta-
tive trans-membrane domains differ in several regions.
TA1 is more hydrophobic over the first five residues which
form the N-terminal flanking region and the last five resi-
dues, which form the C-terminal flanking region (Figure
5B). However, the largest difference between the SLMAP
TAs can be seen in the transmembrane region. TA1 is
much more hydrophobic than TA2 between residues 10
and 20, with TA1 having a maximum score of 1.03 whilst
TA2 reaches 0.8. This data led us to believe that the differ-
ence in hydrophobicity between the two TAs may be
enough to result in differential targeting.
TA2 sequences can target SLMAP1 to mitochondria
The endogenous localisation of SLMAP in COS7 cells was
examined using anti-SLMAP antibodies (Figure 6a) andBMC Cell Biology 2009, 10:48 http://www.biomedcentral.com/1471-2121/10/48
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Overexpression of SLMAP does not affect VSV-G transport from the ER Figure 4
Overexpression of SLMAP does not affect VSV-G transport from the ER. COS7 cells were co-transfected with 
6Myc-SLMAP and ts045-VSV-G-GFP. When maintained at 40°C (a, d, g), the GFP-tagged viral glycoprotein was retained in the 
ER (d) and co-distributed with the Myc-labelled SLMAP protein (a). At 32°C, ts045-VSV-G-GFP exited the ER and was 
observed at perinuclear structures as well as at the cell periphery (e); whereas the 6Myc-SLMAP (b) appeared to remain in the 
ER. In cells incubated at reduced temperatures (15°C), the GFP-tagged viral glycoprotein is redistributed to perinuclear punc-
tuate-like structures indicative of the ERGIC (f). The localization of the 6Myc-SLMAP (c) remained unaltered in these cells. 
Overlay of the anti-Myc and GFP signals is shown in g, h, and i.BMC Cell Biology 2009, 10:48 http://www.biomedcentral.com/1471-2121/10/48
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compared with the mitochondrial marker TOM20 [52]
(Figure 6b). The co-distribution (Figure 6c) shows that a
significant amount of the endogenous SLMAP co-distrib-
utes with TOM20 however there are regions in the cell,
where SLMAP is present without TOM-20. These regions
would be consistent with the presence of SLMAP at the ER
as noted by anti-calnexin staining (Figure 3A; a–c). The
subcellular localization of the ectopically expressed
SLMAP1 variants encoding TA1 and TA2 were further ana-
lysed with respect to Tom20 and MOM localization. Dual
immunostaining using anti-Tom20 and anti-Myc antibod-
ies showed that the 6Myc-SLMAP1-TA1 variant did not
localize at the mitochondria (Figure 6d–e). A mitochon-
drion is indicated by the arrow in Figure 6e. Whereas, co-
distribution of Tom20 with the 6Myc-SLMAP1-TA2 indi-
cated that this variant may target the MOM, whilst still
being present in a filamentous structure throughout the
cytoplasm in a similar way to the TA1 construct (Figure 6g–
i). The filamentous structure targeted by 6Myc-SLMAP1-
TA2 is indicated by an arrow in Figure 6i. It seems clear that
SLMAP1-TA2 targets the mitochondria but in addition it
also shows co-localization with calnexin at the ER (Figure
2A; d–f) which is distinct from the exclusive localization of
SLMAP1-TA1 at the ER (Figure 2A; a–c).
In order to determine the molecular properties of TA2
which are responsible for mitochondrial membrane tar-
geting we performed mutational analysis of the tail
anchor and flanking regions. We used site-directed muta-
genesis to substitute hydrophobic residues for the posi-
Primary sequence and hydrophobicity of TAs in SLMAP Figure 5
Primary sequence and hydrophobicity of TAs in SLMAP. Both of the alternatively spliced SLMAP tail anchors are pre-
dicted to encode a transmembrane helix according to the HMMTOP program. The transmembrane regions are shown in bold 
and underlined, the positively charged residues are shown in a larger font and bold for both TA1 and TA2 (A). The hydropho-
bicity of the TA1 (pink square) and TA2 (blue diamond) was calculated using the Eisenberg normalised scale, with a window 
size of 9, the relative weight for window edges was 100 (B).
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tively charged residues in the flanking regions to see if TA2
was targeted to the mitochondria via these positively
charged residues. The first amino acid in TA2, a lysine res-
idue, was substituted with a leucine residue to remove the
N-terminal flanking positive charge, to create the mutant
TA2-K1/L (Figure 7A). The 27th amino acid, an arginine
residue, was substituted with a leucine residue to remove
the C-terminal flanking positive charge in the mutant
TA2-R27/L (Figure 7B). These two mutations were com-
bined in the mutant TA2-K1/L+R27/L to remove both
flanking positively charged residues (Figure 7C). The Myc
tagged mutant constructs, SLMAP1-TA2-K1/L, SLMAP1-
TA2-R27/L and SLMAP1-TA2-K1/L+R27/L were transfected
into Cos7 cells and compared with GFP tagged SLMAP1-
TA2 for targeting properties. No change in the targeting of
SLMAP1-TA2 was observed due to these mutations sug-
Endogenous SLMAP localises at the mitochondria and is targeted by the TA2 Figure 6
Endogenous SLMAP localises at the mitochondria and is targeted by the TA2. Cells were stained with anti-SLMAP 
(a) and anti-TOM20 (b) to analyze endogenous co-distribution (c). Cos7 cells were transfected with 6Myc-SLMAP1-TA1, and 
co-stained with anti-Tom20 (d) and anti-6Myc (e), the images were then merged (f) arrow points to an anti-Tom20 stained 
mitochondria. Cos7 cells transfected with 6Myc-SLMAP1-TA2 and co-stained with anti-Tom20 (g) and anti-6Myc (h) and the 
images were then merged (i) arrow points to anti-6Myc stained structure with no mitochondria present.BMC Cell Biology 2009, 10:48 http://www.biomedcentral.com/1471-2121/10/48
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gesting that the positive residues are not responsible for
the targeting of TA2 to the mitochondria (Figure 8).
The mutations introduced in TA2 above increased the
hydrophobicity of the flanking sequences, without affect-
ing the hydrophobic profile of the transmembrane region
itself (Figure 9A). To test whether the hydrophobic prop-
erties of the transmembrane sequence in TA2 were impor-
tant for the targeting of SLMAP1 to the mitochondria we
constructed mutants with increased hydrophobicity in
their transmembrane domain. Four mutations were made
in TA2 to construct a mutant TA2 transmembrane region
with similar hydrophobic properties to TA1 (Figure 9B).
The alanine residues 10, 11 and 17 along with threonine
16 were all substituted with leucine residues to make
SLMAP1-TA2 A10/L+A11/L+T16/L+A17/L (SLMAP1-TA2-
4L) (Figure 7E). We transfected Myc tagged SLMAP1-TA2-
4L into Cos7 cells and co-transfected with wild type GFP
tagged SLMAP1-TA2. The TA2-4L mutant did not overlap
with the wild type TA2 in many areas in the cell (Figure
10a–c). When we transfected Cos7 cells with the Myc
tagged SLMAP1-TA2-4L mutant and co-stained with anti-
TOM20 antibodies we saw no overlap with the mitochon-
drial marker (Figure 10d–f). We co-transfected the Myc
tagged SLMAP1-TA2-4L mutant with a GFP tagged wild
type SLMAP1-TA1 the observed overlap indicated that
both constructs target SLMAP1 to the same cellular com-
partment (Figure 10g–i). Thus it appears that the TA2-4L
mutant shares the targeting properties of wild type TA1.
To determine whether a smaller change in hydrophobicity
could produce a similar alteration of targeting, we con-
structed a mutant with two changes in the trans-mem-
brane domain (Figure 9B). The alanine amino acid
residues at positions 10 and 11 were substituted with leu-
cine to create SLMAP1-TA2 A10/L+A11/L (TA2-2L) (Figure
7D). When we co-transfected Myc tagged SLMAP1-TA2-2L
with wild type GFP tagged SLMAP1-TA2 in Cos7 cells we
observed that the TA2-2L mutant only partially co-local-
ised with TA2 (Figure 11a–c). The Myc tagged SLMAP1-
TA2-2L was transfected into Cos7 cells and co-stained
with anti-Tom20 antibodies. There was no overlap
between the TA2-2L mutant and the MOM marker Tom20
(Figure 11d–f). We co-transfected Cos7 cells with Myc
tagged SLMAP1-TA2-2L and wild type GFP tagged
SLMAP1-TA1 and observed nearly complete overlap of the
two (Figure 11g–i). The results of the TA2-4L and TA2-2L
were largely identical, indicating both mutants share the
same targeting properties, which were observed to be the
same as wild type TA1.
The TA2-4L mutant has a transmembrane region that is
only slightly less hydrophobic than the wild type TA1
(Figure 9B) They were found to share similar targeting
properties despite the TA2-4L mutant still possessing pos-
itively charged amino acid residues in both of the regions
flanking its trans-membrane domain, with the corre-
sponding decrease in the hydrophobicity of these regions
(compared with TA1) (Figure 7E). The TA2-2L mutant has
a much less hydrophobic trans-membrane region than
both TA1 and TA2-4L, but is still more hydrophobic than
wild type TA2 over amino acids 6–15 (Figure 9B). How-
ever, it also shares the same targeting properties as TA1;
despite it like TA2-4L possessing flanking positively
charged amino acids (Figure 7D). It appears from this data
that the TA2 transmembrane region is at the very edge of
the hydrophobic range which will target a TA to the MOM.
This may be the reason that TA2 is promiscuous in target-
ing SLMAP1 to mitochondria and ER.
The TA2-K1/L+R27/L mutant which has the positively
charged amino acids replaced with leucine does have an
increase in hydrophobicity compared with wild type TA2
but only in the regions flanking the transmembrane
domain (Figure 9A). The hydrophobicity of the trans-
membrane region of the TA2-K1/L+R27/L mutant remains
the same as the wild type TA2 trans-membrane region
(Figure 9A). These data suggest that the targeting of TA2 to
the mitochondria is due to the reduced hydrophobicity of
the transmembrane region in comparison with the TA1
transmembrane region rather than the presence of the
positively charged amino acid residues in the flanking
sequences.
Discussion
Tail anchored (TA) membrane proteins are important in
several cellular processes including neurotransmitter
release, vesicle transport, membrane fusion and signal
Primary sequence and membrane helix prediction of the TA2  mutants Figure 7
Primary sequence and membrane helix prediction of 
the TA2 mutants. Amino acid substitutions are indicated 
by red bold letters in a larger case. The amino acid residues 
are shown using the single letter code and the transmem-
brane region in each tail anchor is shown in bold and under-
lined. The sequences shown are from Mus musculus.
ET A 2 - 4 L
DT A 2 - 2 L
MPMLLLLVAVTAMVLYV KPWPW PGLARASP^
MPMLLLLVAVLLMVLYV KPWPW PGLARASP^
MPMLAALVAVTAMVLYV LPWPW PGLARASP^
MPMLAALVAVTAMVLYV KPWPW PGLALASP^
BT A 2 - R 2 7 / L
AT A 2 - K 1 / L
CT A 2 - K 1 / L  +  R 2 7 / L
MPMLAALVAVTAMVLYV LPWPW PGLALASP^BMC Cell Biology 2009, 10:48 http://www.biomedcentral.com/1471-2121/10/48
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Targeting of SLMAP1-TA2 and charge Figure 8
Targeting of SLMAP1-TA2 and charge. Wild type GFP-tagged SLMAP-TA2 was co-transfected into Cos7 cells with wild 
type Myc-tagged SLMAP-TA2 and co-stained with anti-GFP (a) and anti-6Myc antibodies (b) the overlay of the two shows that 
there is nearly complete overlap with a stronger GFP signal near the nucleus (c). Wild type GFP-tagged SLMAP-TA2 was co-
transfected with Myc-tagged SLMAP1-TA2 K1/L and co-stained with anti-GFP (d) anti-6Myc (e) the overlay is essentially the 
same as the control (f). Wild type GFP-tagged SLMAP-TA2 was co-transfected with Myc-tagged SLMAP1-TA2 R27/L and co-
stained with anti-GFP (g) and anti-6Myc antibodies (h) the overlay is essentially the same as the control (i). Wild type GFP-
tagged SLMAP-TA2 was co-transfected with Myc-tagged SLMAP-TA2 K1/L + R27/L and co-stained with anti-GFP (j) and anti-
6Myc (k) antibodies the overlay is essentially the same as the control (l).BMC Cell Biology 2009, 10:48 http://www.biomedcentral.com/1471-2121/10/48
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Hydrophobicity of TA2 mutants Figure 9
Hydrophobicity of TA2 mutants. The hydrophobicity of the TA2-4L (light blue circle) and TA2-2L (green triangle) mutants 
was calculated using the Eisenberg normalised scale, with a window size of 9, the relative weight for window edges was 100, 
compared with wild type TA1 (pink square) and TA2 (blue diamond) (A). The hydrophobicity of the TA2-K1/L+R27/L mutant 
(brown triangle) was calculated using the Eisenberg normalised scale, with a window size of 9, the relative weight for window 
edges was 100, compared with wild type TA1 (pink square) and TA2 (blue diamond) (B).
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Targeting of the SLMAP-TA2-4L mutant Figure 10
Targeting of the SLMAP-TA2-4L mutant. The targeting of SLAMP1-TA2 in Cos7 cells can be altered to that of SLMAP1-
TA1 by increasing the hydrophobic moment of the trans-membrane helix with 4 substitutions: A10/L, A11/L, T16/L, and A17/L. 
Wild type GFP-tagged SLMAP1-TA2 was co-transfected with Myc-tagged SLMAP1 TA2 with the 4 substitutions (Myc-TA2-4L) 
and co-stained with anti-GFP (a) and anti-6Myc antibodies (b) the overlay of the two shows that there is incomplete overlap 
(c). In Cos7 cells stained with antibodies to TOM20 (d) and transfected with Myc-TA2-4L and stained with anti-6Myc antibod-
ies (e) there are large numbers of mitochondria which do not colocalise with any of the mutant SLMAP (f). Wild type GFP-
tagged SLMAP1-TA1 was co-transfected with Myc-TA2-4L and co-stained with anti-GFP (g) and anti-6Myc antibodies (h) when 
the two images are overlaid there is almost total co-localization (i).BMC Cell Biology 2009, 10:48 http://www.biomedcentral.com/1471-2121/10/48
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Targeting of the SLMAP1-TA2-2L mutant Figure 11
Targeting of the SLMAP1-TA2-2L mutant. The targeting of SLAMP1-TA2 in Cos7 cells can be altered to that of 
SLMAP1-TA1 by increasing the hydrophobic moment of the membrane spanning section with 2 substitutions: A10/L and A11/L. 
Wild type GFP-tagged SLMAP1-TA2 was co-transfected with Myc-tagged SLMAP1-TA2 with the 2 substitutions (Myc-TA2-2L) 
and co-stained with anti-GFP (a) and anti-6Myc antibodies (b) the overlay of the two shows that there is incomplete overlap 
(c). In cells stained with antibodies to TOM20 (d) and transfected with Myc-TA2-2L and stained with anti-6Myc antibodies (e) 
there are large numbers of mitochondria which do not co-localize with any of the mutant (f). Wild type GFP-tagged SLMAP1-
TA1 was co-transfected with Myc-TA2-2L and co-stained with anti-GFP (h) and anti-6Myc antibodies (i) when the two images 
were merged there was almost total co-localization (j).BMC Cell Biology 2009, 10:48 http://www.biomedcentral.com/1471-2121/10/48
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transduction [1-8]. All tail anchors comprise a C-terminal
hydrophobic transmembrane region which may be
flanked by positively charged residues which are promis-
cuous in terms of sub-cellular targeting [10]. These fea-
tures are present in the SLMAP C-terminal region and may
account for its distinct pattern of localization observed
here in the liver versus Cos 7 cells compared with the car-
diomyocytes [31]. It is notable that endogenous SLMAP
co-localised with the ER marker calnexin and the mito-
chondrial marker TOM20 implying that it is like other TA
proteins such as BCL2 which also reside in these distinct
membranes [5]. The different TAs utilized by SLMAP
appear to be responsible for the targeting of SLMAP1 to
distinct subcellular structures including the ER and mito-
chondria, perhaps the MOM.
The information required for the targeting of SLMAP to intra-
cellular membranes was not contained in specific amino
acids that flank the predicted transmembrane domain but
was dictated by the overall hydrophobic profile of the TA.
We found that SLMAP1 could target either the ER alone or
the ER and the mitochondria in Cos7 cells depending on
which of the two alternative tail anchors (TA1 or TA2) were
being expressed. The disruption of the cytoskeleton with
nocodazole showed that the distribution patterns of
SLMAP1 are dependent on an intact microtubule network.
This is wholly consistent with changes in distribution noted
for other ER resident proteins, and the known role of the
cytoskeleton in anchoring intracellular membranes in place
[39,53]. It is interesting to speculate that SLMAP may act as
a potential molecular link between intracellular membranes
and the microtubule based cytoskeleton. Several membrane
associated proteins provide a link between intracellular
membranes and the microtubule cytoskeleton including
CLIPs [53] and the ER membrane protein p63 [39,54]. Such
interactions, which may also involve SLMAP, are crucial for
the positioning and structural maintenance of subcellular
organelles [55].
Tail anchors comprise a single membrane spanning helix
of 17 to 21 amino acid residues at the C-terminal end of
the protein [9,10]. Investigations have shown that the
replacement of basic residues in the regions flanking the
membrane helix with hydrophobic residues can alter the
targeting of TAs [2,24,25]. It would appear that the pres-
ence of positively charged residues in the flanking regions
increases the likelihood of the TA targeting the MOM
instead of the ER [26].
The two different tail anchors in SLMAP are generated by
alternative splicing and both appear to target the protein
to subcellular locations. Both TA1 and TA2 target SLMAP1
to the ER. TA2 also targets SLMAP1 the mitochondria as
evidenced by co-localization with Tom20. We found that
this differential targeting was due to the lower hydropho-
bic content of the trans-membrane helix in TA2 when
compared to the alternatively spliced TA1. Immunohisto-
chemistry indicates that TA1 directs SLMAP1 predomi-
nantly to the ER and not the mitochondria probably due
to the more hydrophobic nature of the transmembrane
domain. We were able to prevent TA2 from targeting the
mitochondria by the substitution of moderately hydro-
phobic amino acids with the highly hydrophobic leucine
residues implying that the important targeting informa-
tion in TA2 is the relative hydrophobicity of the trans-
membrane region. In this regard Bielharz et al., [20]
observed a similar shift in the targeting of Fis1 from the
MOM to the ER when the hydrophobicity of its TA was
increased.
We found no evidence to suggest that the positively
charged amino acids which flank the membrane spanning
helix are responsible for the targeting of TA2 to the mito-
chondria per-se. This is in contrast to the view that basic
amino acids flanking the TA are responsible for MOM tar-
geting [2,7,14,24,25]. It seems more likely that in these
cases the substitution of the positively charged, and there-
fore highly hydrophilic, amino acids results in an increase
in the overall hydrophobicity of the TA and altered target-
ing. However, this did not occur in our TA2 K1/L R27/L
mutants despite the hydrophobicity of the flanking
regions being increased to a level above that of the TA1
isoform. Recently it has been shown that artificial TAs
require a moderately hydrophobic transmembrane region
to target the MOM [28]. Consistent with this speculation,
the directed substitution of 2 amino acid residues in the
flanking region in TA2 of SLMAP1 did not sufficiently
change hydrophobic nature to shift targeting.
The presence of the two alternatively spliced exons encod-
ing tail anchors which target SLMAP1 to different loca-
tions suggests SLMAP1 may perform multiple subcellular
functions. Given the coiled-coil nature of the majority of
the SLMAP protein, it may be that it tethers proteins into
place on both the ER and perhaps the MOM. Alterna-
tively, it may be involved in tethering of the two mem-
brane systems together through homo/hetero-
dimerisation. Differential levels of expression of SLMAP
with the different TAs, suggest that SLMAP may serve var-
ying subcellular roles in tissue specific manner [8,30,31].
In this regard, the expression levels of SLMAP were found
to be important for normal myoblast fusion [29]. SLMAP
was not found to be localized with the vesicle transport
mechanism nor did its over expression affect vesicle trans-
port in Cos7 cells, this implies that it is not involved in
intracellular trafficking.
While the mechanism of TA protein membrane insertion
remains to be defined, it appears that both the SRP (signal
recognition particle) and a novel mechanism utilizing
ATP appear to be involved [56,57]. Which of these mech-
anisms is utilised by SLMAP remains unknown.BMC Cell Biology 2009, 10:48 http://www.biomedcentral.com/1471-2121/10/48
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Conclusion
Our data here supports the view that the sub-cellular tar-
geting of SLMAP is determined by the overall hydropho-
bicity of its alternative tail-anchor (TA). Further, the basic
amino acid residues in the regions flanking the transmem-
brane helix contribute to the overall hydrophobic profile
of the TA and its targeting rather then the individual resi-
dues being a targeting signal. Further more, the potential
association of SLMAP with the MOM implies additional
roles for this molecule in mitochondrial function.
Methods
Membrane helix predictions were performed using the
HMMTOP program [49,50]. Hydropathy calculations
were performed using the ProtScale tool http://
www.expasy.org/cgi-bin/protscale.pl with the Eisenberg
algorithm using a window size of 9 and the relative weight
for the window edges was 100%. [51].
DNA constructs
Since the targeting of the tail anchored proteins resides at
the C-terminal regions in general we used GFP and 6Myc-
tagged expression constructs of the naturally occurring
SLMAP1-TA1, SLMAP1-TA2, as previously described
[29,31,32].  Site directed mutagenesis was performed
using the Stratagene "Quikchange" kit. Template DNA
concentration was 30 mg per reaction. The K1/I mutant
(AAA/ATA) was created using 5' (GGA AAT AAT ATA CCC
TGG CCC) and 3' (GGG CCA GGG TAT ATT ATT TCC).
The R27/I mutant (AGA/ATA) was created using 5' (CCA
GGT CTG GCC ATA GCT TCT CCG TG) and 3' (CA CGG
AGA AGC TAT GGC CAG ACC TGG). The K1/I+R27/I
mutant was created by performing SDM on the K1/I
mutant using the R27/I primers (5' (CCA GGT CTG GCC
ATA GCT TCT CCG TG) and 3' (CA CGG AGA AGC TAT
GGC CAG ACC TGG)). The P4/L mutant (CCC/CTC) was
created using 5' (ATA CCC TGG CTC TGG ATG CCC) and
3' (GGG CAT CCA GAG CCA GGG TAT). The A10/L + A11/
L mutant (GCT/CTT + GCC/CTC) was created using 5'
(ATG CCC ATG TTG CTT CTC CTG GTT GCG GTG) and
3' (CAC CGC AAC CAG GAG AAG CAA CAT GGG CAT).
The T16/L + A17/L mutant (ACA/CTA + GCT/CTC) was cre-
ated using 5' (CTG GTT GCG GTG CTA CTC ATC GTG
CTG TAT) and 3' (ATA CAG CAC GAT GAG TAG CAC
CGC AAC CAG). The A10/L+A11/L+T16/L+ A17/L mutant
was created by SDM on the A10/L+A11/L construct using
the T16/L + A17/L creation primers (5' (CTG GTT GCG GTG
CTA CTC ATC GTG CTG TAT) and 3' (ATA CAG CAC GAT
GAG TAG CAC CGC AAC CAG)).
Cell culture, transfections and cytoskeletal disruptions
COS7 African green monkey kidney and C2C12 cells were
maintained at 37°C in Dulbecco modified essential
media (DMEM) supplemented with 10% heat inactivated
fetal bovine serum and antibiotics. Transient transfection
experiments were performed using the fugene™ (Roche
Biochemicals) transfection reagent according to the man-
ufacturers' specifications. Disruptions of microtubules
were induced in COS7 cells with 10 mM nocodazole
(Sigma-Aldrich) for two hours at 37°C. Filamentous actin
was disrupted in COS7 cells with 1 mM cytochalain D
(Sigma-Aldrich) for 2 hours at 37°C. Cell Culture and
Immunohistochemistry. Transfections were performed
as previously described [30], and visualised using specific
antibodies, anti-Myc 9E10 (Roche), anti-TOM20 (Santa
Cruz), anti-GFP (Roche), and anti-Calnexin (StressGen)
with an Axiophot (Carl Zeiss) fluorescent microscope and
images captured as described previously [29]. For endog-
enous co-localisation studies either C2C12 cells or COS7
cells were stained with anti-SLMAP antibodies and either
anti-Calnexin or anti-Tom20.
Subcellular fractionation of the Golgi and ER
Stacked Golgi fractions (SGF) and endoplasmic reticulum
fractions were isolated from rabbit liver according to the
method described by Taylor et al., [34]. All procedures
were performed on ice in the presence of protease inhibi-
tors (PMSF, leupeptin, aprotonin, pepstatin A). Freshly
removed livers were minced and then homogenized (0.5
M phosphate buffered sucrose. 100 mM KH2PO4/K2HPO4
pH 6.5 and 5 mM MgCl2). The homogenate was centri-
fuged at 1500 × g for 10 minutes to remove unbroken
cells, debris and nuclei. Postnuclear supernatant (PNS)
was loaded onto a sucrose step gradient (1.3 M sucrose,
0.86 M sucrose, PNS in 0.5 M sucrose, 0.25 M sucrose)
and centrifuged at 100,000 × g for one hour. Fractions col-
lected from the gradient included S1 (0.25–0.5 M inter-
face), A1 (0.5 M layer), S2 (0.5–0.86 M interface), B1
(0.86 M layer), S3 (0.86–1.3 M interface), C1 (1.3 M
layer), and pellet (P). S2 fraction was adjusted to 1.15 M
sucrose, and then overlaid with 1.0 M sucrose, 0.86 M
sucrose and 0.25 M sucrose. This sucrose gradient was
centrifuged at 76,000 × g for 3 hours. Fractions collected
included: SGF1 (0.26–0.86 M interface), SGF2 (0.86–1.0
M interface), C2 (1.0 M layer), SGF3 (1.0–1.15 M inter-
face), and SGFL (1.15 M layer). Protein content of each
fraction was determined via the BCA protein assay
(Pierce). Equal amounts (10 mg) of each fraction were
loaded onto a 10% SDS polyacrylamide gel. ER-Golgi
protein transport assays The ts045-VSVG-GFP expression
plasmid was donated by Dr. Lippincott-Schwartz [37].
The plasmid was co-transfected with 6Myc-tagged SLMAP-
pcDNA3 constructs into COS7 at 40°C for 15 hours. Cells
were then shifted to either 32°C for one hour or 15°C for
three hours to monitor the transport of ts045-VSVG-GFP
from the ER to the ERGIC, Golgi and plasma membrane.
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